Trending...
- THE OIL TRUTH: They Never Wanted Us To Remember: How Engineered Scarcity Kept America In Chains For Generations
- Your Local Pro Expands National Service Network to 273+ Locations Across Plumbing, Cleaning, Landscaping and Hydrovac
- Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement
BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a national specialty pharmacy benefit manager (SPBM™) serving commercial, Medicare and Medicaid segments, announces the release of its white paper, "Specialty RX Cost Containment Expertise Successfully Addresses Impact of Social Determinants of Health for Individuals with Rare Diseases," authored by Dea Belazi, president and CEO. Belazi describes the impact of a competitive marketplace where manufacturers increasingly recognize that payers and healthcare systems are choosing to partner with specialty medical Rx pharmacy benefit managers (PBMs), such as AscellaHealth. These relationships are proving to better address social determinants of health (SDoH) and contain costs associated with specialty drugs.
More on The PennZone
"SDoH is the umbrella term for conditions in which people are born, live, learn, work, play, worship and age, affecting a wide range of health, functioning and quality-of-life outcomes and accounting for up 80-90% of a health outcome," says Belazi. "While healthcare providers do their best to understand as much about the patient's life as possible, they don't always have the time or reach to fully understand the impact of SDoH for each person. AscellaHealth's specialty medical pharmacy management is designed to address these issues in order to reduce costs, increase specialty drug availability and improve patient outcomes through appropriate medication therapy management."
There is increased focus on SDoH among specialty pharmaceutical manufacturers seeking commercialization opportunities as the year-over-year growth in specialty drug revenue and new drug applications for specialty therapeutics at the FDA signals a fast-growth industry trend toward specialty drugs, Manufacturers now take into account the social risk factors that guide planning, including access to affordable healthcare services and medications, opportunities to leverage emerging communication technologies and services that support health literacy and the adoption of telehealth services.
More on The PennZone
Belazi adds, "Our approach serves as a collaborative model for helping clients find resources and support. Ultimately, our focus on SDoH—and putting the patient/member at the center of care —reflects our commitment to providing a robust, safe and affordable drug benefit to members while improving outcomes and reducing costs."
About AscellaHealth
AscellaHealth, a national specialty pharmacy benefit manager (SPBM™), serving commercial, Medicare and Medicaid segments, offers high quality prescription drug benefit management services. Complemented by other customizable services, such as carved-out specialty pharmacy services and cost-savings programs, AscellaHealth provides a unique, proprietary service portfolio. Visit www.ascellahealth.com.
More on The PennZone
- Derek Cook's Roofing Encourages Homeowners to Prepare for Fall Weather
- Boston Industrial Solutions Expands Product Offering with Pad Printing Pads and Silicone for Custom Pad Manufacturing
- Rodeo FX Originals Appoints Yvann Thibaudeau Head of Development & IP
- Phoenix 5/7 Emerges as a Genre-Fluid Artist Collective
- Massage Revolution Expands to Santa Monica With New Wilshire Boulevard Location
"SDoH is the umbrella term for conditions in which people are born, live, learn, work, play, worship and age, affecting a wide range of health, functioning and quality-of-life outcomes and accounting for up 80-90% of a health outcome," says Belazi. "While healthcare providers do their best to understand as much about the patient's life as possible, they don't always have the time or reach to fully understand the impact of SDoH for each person. AscellaHealth's specialty medical pharmacy management is designed to address these issues in order to reduce costs, increase specialty drug availability and improve patient outcomes through appropriate medication therapy management."
There is increased focus on SDoH among specialty pharmaceutical manufacturers seeking commercialization opportunities as the year-over-year growth in specialty drug revenue and new drug applications for specialty therapeutics at the FDA signals a fast-growth industry trend toward specialty drugs, Manufacturers now take into account the social risk factors that guide planning, including access to affordable healthcare services and medications, opportunities to leverage emerging communication technologies and services that support health literacy and the adoption of telehealth services.
More on The PennZone
- "Warrior Defined" Event Brings Men Together in Charlotte, With Calls for Events Across the U.S
- Dion Abadi Publishes Free Collector Tips Hub for Art and Jewelry Buyers
- World-Renowned Body Language Expert Mark Bowden Headlines INSPIRE Northwest 2026 in Wenatchee, WA
- ASN Software Introduces New California CARS Act Dealer Updates
- USA Air Management Marks 30 Years of Air Duct Cleaning in NJ Urges Homeowners to Schedule Dryer Vent Cleaning Before Heating Season
Belazi adds, "Our approach serves as a collaborative model for helping clients find resources and support. Ultimately, our focus on SDoH—and putting the patient/member at the center of care —reflects our commitment to providing a robust, safe and affordable drug benefit to members while improving outcomes and reducing costs."
About AscellaHealth
AscellaHealth, a national specialty pharmacy benefit manager (SPBM™), serving commercial, Medicare and Medicaid segments, offers high quality prescription drug benefit management services. Complemented by other customizable services, such as carved-out specialty pharmacy services and cost-savings programs, AscellaHealth provides a unique, proprietary service portfolio. Visit www.ascellahealth.com.
0 Comments
Latest on The PennZone
- Vegan Chef KESS Celebrates Parade.com Feature and Expands Into Wedding Catering
- Port St. Lucie REALTOR® Irene Pernice Earns SFR® Certification
- AMR and UAS Take the Stage at WorldSkills Shanghai 2026
- Benchmark International Facilitated the Trans of P&Ro Solutions Group and FOCUS Learning Corporation
- Biophysical Therapeutics brings longevity science to skincare with its new IF1 brand
- JoCa's Echoes of Haworth Sells Out on Opening Night in Mexico City; Artist Heads to San Luis Potosí and Miami Art Week
- Home2 Suites by Hilton Lee's Summit, MO Opens to Guests
- Shanghai Chengwei Semiconductor Equipment Launches High Precision Laboratory Central Gas Supply System
- Your Local Pro Expands National Service Network to 273+ Locations Across Plumbing, Cleaning, Landscaping and Hydrovac
- YWCA Hanover to Host Ribbon Cutting for New Children's Learning Academy
- Acuvance Coker Study Finds Experience, Not Supply, Is the Biggest Advanced Practice Provider Workforce Challenge
- Uk Financial Moonshot Token™ Robinhood-chain Goes Live On Tokpie Exchange Tomorrow, With Solana Side Of UKFLMS To Follow In Global Listing Expansion
- THE OIL TRUTH: They Never Wanted Us To Remember: How Engineered Scarcity Kept America In Chains For Generations
- Solid Earth's new "Welcome to Real Estate" campaign introduces RealtyID™: Know Before Your Open the Door
- Keystone Consulting Engineers Expands into Brodheadsville, Strengthening Regional Engineering
- Radio Drive's New Album Walk With Me Delivers Two GRAMMY® Submissions Across Rock and Alternative Categories
- Kaplan Morrell and Attorney Jacqui Condon Selected to Represent Professional Women's Soccer Players in Workers' Compensation Matters
- ClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC Research
- Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement
- Revenue Optics Names Prat Patibandla Director of Growth Marketing